Biotech & Pharma

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

28 sec read5 views0 listens

Merck has partnered with Protillion Biosciences to accelerate drug discovery through a collaboration potentially worth up to $510 million. This initiative leverages Protillion's AI-driven "lab-in-the-loop" platform, combining extensive wet-lab data with advanced machine learning to identify optimized therapeutic candidates at unprecedented speed and scale. This development signifies a significant integration of cutting-edge computational and experimental approaches in biopharma, impacting how drug developers approach complex molecule design and optimization.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio has launched a comprehensive DNA-Encoded Library (DEL) discovery service to aid in the identification of drug targets that are difficult or novel. This integrated platform combines multiple techniques, including protein production, biophysical ...

Ali Nemati

Education & EdTech1 day ago27 sec read

Mississippi High in Education, Last in Child Health Outcomes

Mississippi ranks 16th nationally in education, marking its highest score ever according to the Annie E. Casey Foundation's KIDS COUNT Data Book, but it remains at the bottom for child health outcomes. This disparity highlights the need for comprehen...

Ali Nemati

Health & Medicine1 day ago26 sec read

STAT+: FDA approves Colorado's plan to import cheaper drugs from Canada

The FDA has approved Colorado's plan to import cheaper prescription drugs from Canada, following Florida’s lead. This move aims to alleviate high drug costs for residents but faces challenges such as opposition from the Canadian pharmaceutical indust...

Ali Nemati

Biotech & Pharma2 days ago28 sec read

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

Parabilis Medicines achieved a record-breaking $770.5 million IPO, the largest ever for a drug developer, with its stock experiencing a significant initial jump. This event is highly relevant for developers and professionals in the biotech and pharma...

Ali Nemati

Education & EdTech3 days ago28 sec read

Wyoming Students Spend Less Time in PE. An Expert Wants to Change That.

Wyoming elementary students are receiving insufficient physical education time, with an average of only 73 minutes per week, far below national recommendations. An expert advocates for strengthening PE requirements, including minimum weekly instructi...

Ali Nemati

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Related Articles

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

Mississippi High in Education, Last in Child Health Outcomes

STAT+: FDA approves Colorado's plan to import cheaper drugs from Canada

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

Wyoming Students Spend Less Time in PE. An Expert Wants to Change That.